Cleared Traditional

K984545 - RELEASE 2 OF PHILIPS INTEGRIS SERIES (V...

K984545 is the FDA 510(k) clearance for RELEASE 2 OF PHILIPS INTEGRIS SERIES (V... by Philips Medical Systems North America, Inc.. It is a Class 2 Radiology device (product code IZI) cleared through the Traditional 510(k) pathway after a 65-day FDA review.

K984545 · Philips Medical Systems North America, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1999
Decision
65d
Days
Class 2
Risk

K984545 is an FDA 510(k) clearance for the RELEASE 2 OF PHILIPS INTEGRIS SERIES (V5000, BV5000, H5000, BH5000, HM2000) S.... Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Philips Medical Systems North America, Inc. (Da Best, NL). The FDA issued a Cleared decision on February 25, 1999 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Philips Medical Systems North America, Inc. devices

Submission Details

510(k) Number K984545 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1998
Decision Date February 25, 1999
Days to Decision 65 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 107d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 99
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K984545.
KOORDINANT ANGIOGRAPHIC AND OPERATING ROOM MODEL X-RAY TABLE FAMILY
K993947 · Siemens Corp. · Dec 1999
DIGITAL IMAGING SYSTEM (BSR)
K991922 · Siemens Medical Solutions USA, Inc. · Sep 1999
HITACHI VERSIFLEX
K991231 · Hitachi Medical Systems America, Inc. · May 1999
PHILIPS INTEGRIS 3D RA OPTION
K983877 · Philips Medical Systems North America, Inc. · Dec 1998
ADVANTX LCN, ADVANTX LCLP
K974367 · GE Medical Systems · Feb 1998
LEG'MAP OPTION
K973270 · Ge Medical Systems, Inc. · Nov 1997